Thus, several inflammatory mediators such as high C-reactive protein (CRP) and circulating pro-inflammatory markers such as tumor necrosis factor-α (TNF-α) and interleukins are involved in the pathogenesis of IBD, as well as in atherosclerosis [7]. This evidence concerns the gene CRP and atherosclerosis.